Nosology of idiopathic transverse myelitis syndromes

Acta Neurologica Scandinavica

Volumn 115, Issue 6, 2007, Pages 371-376

  Scott, Thomas F ^a,b  

^a DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

^b East Wing Office Building   (United States)

Author keywords

Devic's syndrome; Multiple sclerosis; Partial myelitis; Transverse myelitis

Indexed keywords

AZATHIOPRINE; BETA INTERFERON; IMMUNOSUPPRESSIVE AGENT; RITUXIMAB; STEROID;

ACUTE COMPLETE TRANSVERSE MYELITIS; ACUTE PARTIAL TRANSVERSE MYELITIS; ANTIPHOSPHOLIPID SYNDROME; CEREBROSPINAL FLUID; CLINICAL FEATURE; DISEASE CLASSIFICATION; DISEASE SEVERITY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; MULTIPLE SCLEROSIS; MYELITIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PLASMAPHERESIS; RELAPSE; RELAPSING MYELITIS; RELIABILITY; REVIEW; RISK ASSESSMENT; SECONDARY MYELITIS; SJOEGREN SYNDROME; STEROID THERAPY; SYSTEMIC LUPUS ERYTHEMATOSUS;

DISEASE PROGRESSION; HUMANS; MAGNETIC RESONANCE IMAGING; MULTIPLE SCLEROSIS; MYELITIS, TRANSVERSE; NEUROMYELITIS OPTICA; PREDICTIVE VALUE OF TESTS; PROGNOSIS; RECURRENCE; SPINAL CORD;

EID: 34248669299     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2007.00835.x     Document Type: Review

References (33)

1. Ford B, Tampieri D, Francis G. Long-term follow-up of acute partial transverse myelopathy. Neurology 1992 42: 250 2.
2. Berman M, Feldman S, Alter M et al. Acute transverse myelitis: incidence and etiologic considerations. Neurology 1981 31: 966 71.
3. Jeffery DR, Mandler RN, Davis LE. Transverse myelitis (retrospective analysis of 33 cases, with differentiation of cases associated with multiple sclerosis and parainfectious events). Arch Neurol 1993 50: 532 6.
4. Altrocchi RH. Acute transverse myelopathy. Arch Neurol 1962 9: 21 9.
5. Lipton HL, Teasdall RD. Acute transverse myelopathy in adults: a follow-up study. Arch Neurol 1973 28: 252 7.
6. Scott TF, Kassab SL, Singh S. Acute partial transverse myelitis with normal cerebral magnetic resonance imaging: transition rate to clinically definite multiple sclerosis. Mult Scler 2005 11: 373 7.
7. Morrissey SP, Miller DH, Kendall BE et al. The significance of brain magnetic resonance imaging abnormalities at presentation with clinically isolated syndromes suggestive of multiple sclerosis. Brain 1993 116: 135 46.
8. Bashir K, Whitaker JN. Importance of paraclinical and CSF studies in the diagnosis of MS in patients presenting with partial cervical transverse myelopathy and negative cranial MRI. Mult Scler 2000 6: 312 6.
9. Scott TF, Bhagavatula K, Snyder PJ et al. Transverse myelitis comparison with spinal cord presentations of multiple sclerosis. Neurology 1998 50: 429 33.
10. Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002 59: 499 505.
11. Wingerchuk DM, Hogancamp WF, O'Brien PC et al. The clinical course of neuromyelitis optica (Devic's syndrome). Neurology 1999 53: 1107 14.
12. Wingerchuk DM, Lennon VA, Pittock SJ et al. Revised diagnostic criteria for neuromyelitis optica. Neurology 2006 66: 1485 9.
13. Lennon VA, Wingerchuk DM, Kryzer TJ et al. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet 2004 364: 2106 12.
14. Simnad VI, Pisani DE, Rose JW. Multiple sclerosis presenting as transverse myelopathy: clinical MRI features. Neurology 1997 48: 65 73.
15. Jacobs LD, Beck RW, Simon JH et al. Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. N Engl J Med 2000 343: 898 904.
16. Tippett DS, Fishman PS, Panitch HS. Relapsing transverse myelitis. Neurology 1991 41: 703.
17. Kim K. Idiopathic recurrent transverse myelitis. Arch Neurol 2003 60: 1290.
18. Hummers LK, Krishman C, Casciola-Rosen L et al. Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology 2004 62: 147 9.
19. Andersen O. Myelitis. Curr Opin Neurol 2000 13: 311 6.
20. Martinelli V, Comi G, Rovaris M et al. Acute myelopathy of unknown aetiology: a clinical, neurophysiological and MRI study of short- and long-term prognostic factors. J Neurol 1995 242: 497 503.
21. Dalecky A, Pelletier J, Ali Cherif A et al. Myélopathies aigu du sujet jeune et sclérose en plaques. Rev Neurol (Paris) 1997 153: 10.
22. Cordonnier C, De Seze J, Breteau G et al. Prospective study of patients presenting with acute partial transverse myelopathy. J Neurol 2003 250: 1447 52.
23. Poser CM, Paty DW, Scheinberg L et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 1983 13: 227 31.
24. McDonald WI, Compston A, Edan G et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the Diagnosis of Multiple Sclerosis. Ann Neurol 2001 50: 121 7.
25. Pittock SJ, Lennon VA, Krecke K et al. Brain MRI abnormalities in neuromyelitis optica. Arch Neurol 2006 63: 390.
26. Weinshenker BG, Wingerchuk DM, Vukusic S et al. Neuromyelitis optica IgG predicts relapse after longitudinally extensive transverse myelitis. Ann Neurol 2006 59: 566 9.
27. Scott TF, Kassab S, Pittock SJ. Neuromyelitis optica antibodies and acute partial transverse myelitis. Arch Neurol 2006 63: 1398 400.
28. Bakshi R, Kinkel PR, Mechtler LL et al. Magnetic resonance imaging findings in 22 cases of myelitis: comparison between patients with and without multiple sclerosis. Eur J Neurol 1998 5: 35 48.
29. Scott T, Weikers N, Hospodar M et al. Acute transverse myelitis: a retrospective study using magnetic resonance imaging. Can J Neurol Sci 1994 21: 133 6.
30. Weinshenker BG, O'Brien PC, Petterson TM et al. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 1999 46: 878 86.
31. Mandler RN, Ahmed W, Dencoff JE. Devic's neuromyelitis optica: a prospective study of seven patients treated with prednisone and azathioprine. Neurology 1998 51: 1219 20.
32. Papeix C, Deseze J, Pierrot-Deseilligny C et al. French therapeutic experience of Devic's disease: a retrospective study of 33 cases. Neurology 2005 64 (Suppl. 1 A328.
33. Cree BAC, Lamb S, Morgan K, Chen A, Waubant E, Genain C. An open label study of the effects of rituximab in neuromyelitis optica. Neurology 2005 64: 1270 2.